Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
R. E. Nappi, L. Tiranini, E. Martini, D. Bosoni, C. Cassani & L. Cucinella. (2023) Different local estrogen therapies for a tailored approach to GSM. Climacteric 26:4, pages 361-366.
Read now
Read now
Ki-Jin Ryu, Kyong Wook Yi, Yong Jin Kim, Jung Ho Shin, Jun Young Hur, Tak Kim, Jong Bae Seo, Kwang-Sig Lee & Hyuntae Park. (2022) Artificial intelligence approaches to the determinants of women’s vaginal dryness using general hospital data. Journal of Obstetrics and Gynaecology 42:5, pages 1518-1523.
Read now
Read now
D. Herbert, R. J. Bell, K. Young, H. Brown, J. Y. Coles & S. R. Davis. (2020) Australian women’s understanding of menopause and its consequences: a qualitative study. Climacteric 23:6, pages 622-628.
Read now
Read now
R. J. Baber, N. Panay & A. Fenton$suffix/text()$suffix/text(). (2016) 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 19:2, pages 109-150.
Read now
Read now
Barbara Gardella, Anna Daniela Iacobone, Daniele Porru, Valentina Musacchi, Mattia Dominoni, Carmine Tinelli, Arsenio Spinillo & Rossella E. Nappi. (2015) Effect of local estrogen therapy (LET) on urinary and sexual symptoms in premenopausal women with interstitial cystitis/bladder pain syndrome (IC/BPS). Gynecological Endocrinology 31:10, pages 828-832.
Read now
Read now
Rossella E Nappi. (2015) Why are there no FDA-approved treatments for female sexual dysfunction?. Expert Opinion on Pharmacotherapy 16:12, pages 1735-1738.
Read now
Read now
Rossella E Nappi & Laura Cucinella. (2015) Advances in pharmacotherapy for treating female sexual dysfunction. Expert Opinion on Pharmacotherapy 16:6, pages 875-887.
Read now
Read now
B. M. Zeleke, S. R. Davis, P. Fradkin & R. J. Bell. (2015) Vasomotor symptoms and urogenital atrophy in older women: a systematic review. Climacteric 18:2, pages 112-120.
Read now
Read now
S. Salvatore, R. E. Nappi, M. Parma, R. Chionna, F. Lagona, N. Zerbinati, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2015) Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 18:2, pages 219-225.
Read now
Read now
S. Salvatore, R. E. Nappi, N. Zerbinati, A. Calligaro, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2014) A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 17:4, pages 363-369.
Read now
Read now
R. E. Nappi & S. Palacios. (2014) Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 17:1, pages 3-9.
Read now
Read now
Ginger D. Constantine, Nico Bruyniks, Nicole Princic, Daniel Huse, Liisa Palmer, Greg Lenhart, William A. Blumentals & Rossella E. Nappi. (2014) Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy. Current Medical Research and Opinion 30:1, pages 143-148.
Read now
Read now
Sharon J Parish, Rossella E Nappi, Michael L Krychman, Susan Kellogg-Spadt, James A Simon, Jeffrey A Goldstein & Sheryl A Kingsberg. (2013) Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. International Journal of Women's Health 5, pages 437-447.
Read now
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Read now
R. D. Langer, J. E. Manson & M. A. Allison. (2012) Have we come full circle – or moved forward? The Women's Health Initiative 10 years on. Climacteric 15:3, pages 206-212.
Read now
Read now
Articles from other publishers (62)
Susan R. Davis, JoAnn Pinkerton, Nanette Santoro & Tommaso Simoncini. (2023) Menopause—Biology, consequences, supportive care, and therapeutic options. Cell 186:19, pages 4038-4058.
Crossref
Crossref
Anne E. Turco & Chad M. Vezina. 2023. Neuro-Urology Research. Neuro-Urology Research
141
158
.
. (2022) The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 29:7, pages 767-794.
Crossref
Crossref
Roger A Lobo & Anne Gompel. (2022) Management of menopause: a view towards prevention. The Lancet Diabetes & Endocrinology 10:6, pages 457-470.
Crossref
Crossref
Rossella E. Nappi, Lara Tiranini, Ellis Martini, David Bosoni, Alessandra Righi & Laura Cucinella. (2022) Medical Treatment of Female Sexual Dysfunction. Urologic Clinics of North America 49:2, pages 299-307.
Crossref
Crossref
Rossella E. Nappi & Laura Cucinella. (2022) Sexuality, pelvic floor/vaginal health and contraception at menopause. Best Practice & Research Clinical Obstetrics & Gynaecology 81, pages 85-97.
Crossref
Crossref
Roger A. Lobo. 2022. Comprehensive Gynecology. Comprehensive Gynecology
255
288.e9
.
Rossella E. Nappi, Laura Cucinella, Ellis Martini & Chiara Cassani. (2021) The role of hormone therapy in urogenital health after menopause. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101595.
Crossref
Crossref
Andrea R Genazzani, Patrizia Monteleone, Andrea Giannini & Tommaso Simoncini. (2021) Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human Reproduction Update 27:6, pages 1115-1150.
Crossref
Crossref
Stefano Salvatore, Rossella E. Nappi, Arianna Casiraghi, Alessandro F. Ruffolo, Rebecca Degliuomini, Marta Parma, Umberto Leone Roberti Maggiore, Stavros Athanasiou & Massimo Candiani. (2021) Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up. Clinical Breast Cancer 21:5, pages e539-e546.
Crossref
Crossref
Yulia E. Dobrokhotova, Polina A. Shadrova & Vladimir I. Komagorov. (2021) Vaginal microbiota during the menopausal transition: the role of lactobacilli. Gynecology 23:3, pages 214-221.
Crossref
Crossref
Rakibul M. Islam, Susan R. Davis, Robin J. Bell, Trevor Tejada-Berges, Caspar David Wrede, Susan M. Domchek, Bettina Meiser, Judy Kirk, Efrosinia O. KrejanyMartha Hickey. (2021) A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy. Menopause 28:7, pages 748-755.
Crossref
Crossref
Jason Cruff & Salil Khandwala. (2021) A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause. The Journal of Sexual Medicine 18:4, pages 761-769.
Crossref
Crossref
Tiziana Pagano, Antonio Travaglino, Antonio Raffone, Roberta Vallone, Cira Buonfantino, Pasquale De Rosa, Mariavittoria Locci, Elia Guadagno, Luigi Insabato, Stefano Salvatore & Giuseppe De Placido. (2020)
Fractional Microablative CO
2
Laser‐Related Histological Changes on Vulvar Tissue in Patients With Genitourinary Syndrome of Menopause
. Lasers in Surgery and Medicine 53:4, pages 521-527.
Crossref
Crossref
Johannes Bitzer & Paraskevi-Sofia Kirana. 2021. Psychiatry and Sexual Medicine. Psychiatry and Sexual Medicine
109
134
.
. (2020) The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 27:9, pages 976-992.
Crossref
Crossref
Sa Ra LeeMoon Kyoung ChoYeon Jean ChoSungwook ChunSeung-Hwa HongKyu Ri HwangGyun-Ho JeonJong Kil JooSeul Ki KimDong Ock LeeDong-Yun LeeEun Sil LeeJae Yen SongKyong Wook YiBo Hyon YunJung-Ho ShinHee Dong Chae & Tak Kim. (2020) The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine 26:2, pages 69.
Crossref
Crossref
Juan Tovar‐Huamani, Felipe Mercado‐Olivares, Jose Antonio Grandez‐Urbina, Rafael Pichardo‐Rodriguez, Marco Tovar‐Huamani & Herney García‐Perdomo. (2019)
Efficacy of fractional CO
2
laser in the treatment of genitourinary syndrome of menopause in Latin‐American Population: First Peruvian experience
. Lasers in Surgery and Medicine 51:6, pages 509-515.
Crossref
Crossref
No Author. (2019) Chapitre 8 : Sexualité et ménopause. Journal of Obstetrics and Gynaecology Canada 41, pages S103-S121.
Crossref
Crossref
Rogerio A. Lobo. 2019. Yen and Jaffe's Reproductive Endocrinology. Yen and Jaffe's Reproductive Endocrinology
322
356.e9
.
Rafael Sánchez-Borrego. 2019. Postmenopausal Diseases and Disorders. Postmenopausal Diseases and Disorders
327
348
.
Brooke A. Harnisch, Mary Soyster & Phillip P. Smith. 2019. Healthy Aging. Healthy Aging
93
103
.
Susan R Davis, Penelope J Robinson, Fiona Jane, Shane White, Michelle White & Robin J Bell. (2018) Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors. The Journal of Clinical Endocrinology & Metabolism 103:11, pages 4146-4154.
Crossref
Crossref
. (2018) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 25:11, pages 1362-1387.
Crossref
Crossref
Pragya Gartoulla, Roisin Worsley, Robin J. Bell & Susan R. Davis. (2018) Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause 25:11, pages 1331-1338.
Crossref
Crossref
James A. Simon, Irwin Goldstein, Noel N. Kim, Susan R. Davis, Susan Kellogg-Spadt, Lior Lowenstein, JoAnn V. Pinkerton, Cynthia A. Stuenkel, Abdulmaged M. Traish, David F. Archer, Gloria Bachmann, Andrew T. Goldstein, Rossella E. Nappi & Linda Vignozzi. (2018) The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Menopause 25:7, pages 837-847.
Crossref
Crossref
Robin J. Bell, Farwa Rizvi, Rakabul M. Islam & Susan R. Davis. (2018) A systematic review of intravaginal testosterone for the treatment of vulvovaginal atrophy. Menopause 25:6, pages 704-709.
Crossref
Crossref
Martin Birkhaeuser. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond
43
75
.
Marta Caretto, Andrea Giannini, Eleonora Russo, Paolo Mannella & Tommaso Simoncini. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond
303
316
.
Eleonora Russo, Andrea Giannini, Marta Caretto, Paolo Mannella & Tommaso Simoncini. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond
287
292
.
Sheryl A. Kingsberg, Stanley Althof, James A. Simon, Andrea Bradford, Johannes Bitzer, Joana Carvalho, Kathryn E. Flynn, Rossella E. Nappi, Jennifer B. Reese, Roya L. Rezaee, Leslie Schover & Jan L. Shifrin. (2017) Female Sexual Dysfunction—Medical and Psychological Treatments, Committee 14. The Journal of Sexual Medicine 14:12, pages 1463-1491.
Crossref
Crossref
Kiril L. Hristov, Shankar P. Parajuli, Aaron Provence, Eric S. Rovner & Georgi V. Petkov. (2017)
Nongenomic modulation of the large conductance voltage- and Ca
2+
-activated K
+
channels by estrogen: A novel regulatory mechanism in human detrusor smooth muscle
. Physiological Reports 5:14, pages e13351.
Crossref
Crossref
. (2017) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24:7, pages 728-753.
Crossref
Crossref
Sourav Sanchit Patnaik, Antonio Simone Laganà, Salvatore Giovanni Vitale, Salvatore Butticè, Marco Noventa, Salvatore Gizzo, Gaetano Valenti, Agnese Maria Chiara Rapisarda, Valentina Lucia La Rosa, Carlo Magno, Onofrio Triolo & Vani Dandolu. (2017) Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Archives of Gynecology and Obstetrics 295:6, pages 1341-1359.
Crossref
Crossref
P. Antonio. Maldonado, T. Ignacio Montoya, Jesus F. Acevedo, Patrick W. Keller & R. Ann Word. (2017) Effects of vaginal conjugated equine estrogens and ospemifene on the rat vaginal wall and lower urinary tract†. Biology of Reproduction 96:1, pages 81-92.
Crossref
Crossref
Prof. Rossella E. Nappi, Laura Cucinella, Silvia Martella, Margherita Rossi, Lara Tiranini & Ellis Martini. (2016) Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL). Maturitas 94, pages 87-91.
Crossref
Crossref
Valeria Regina Silva, Cássio Riccetto, Natalia Miguel Martinho, Joseane Marques, Leonardo Cesar Carvalho & Simone Botelho. (2016) Training through gametherapy promotes coactivation of the pelvic floor and abdominal muscles in young women, nulliparous and continents. International braz j urol 42:4, pages 779-786.
Crossref
Crossref
Julie Wong & Douglas G Tincello. (2016) Management of refractory overactive bladder. The Obstetrician & Gynaecologist 18:3, pages 173-181.
Crossref
Crossref
Chen-Li Cheng, Jian-Ri Li, Ching-Heng Lin & William C. de Groat. (2016) Positive association of female overactive bladder symptoms and estrogen deprivation. Medicine 95:28, pages e4107.
Crossref
Crossref
Fang Jiang, Lan Zhu, Tao Xu, Mei-Ying Gong, Yu-Liang Huang, Huai-Fang Li, Jian-Jun Wang, Xiao-Wen Tong, Xiao-Xia Cheng, Wen-Pei Bai, Xin Li, Xue-Xian Xu & Hui-Cheng Xu. (2016) Efficacy and safety of solifenacin succinate tablets versus solifenacin succinate tablets with local estrogen for the treatment of overactive bladder in postmenopausal women—a multicenter, randomized, open-label, controlled comparison study. Menopause 23:4, pages 451-457.
Crossref
Crossref
Nanette Santoro, Roisin Worsley, Karen K. Miller, Sharon J. Parish & Susan R. Davis. (2016) Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction. The Journal of Sexual Medicine 13:3, pages 305-316.
Crossref
Crossref
Ann T. Hanna-Mitchell, Dudley Robinson, Linda Cardozo, Karel Everaert & Georgi V. Petkov. (2016) Do we need to know more about the effects of hormones on lower urinary tract dysfunction? ICI-RS 2014. Neurourology and Urodynamics 35:2, pages 299-303.
Crossref
Crossref
Roisin Worsley, Robin J. Bell, Pragya Gartoulla & Susan R. Davis. (2016) Low use of effective and safe therapies for moderate to severe menopausal symptoms. Menopause 23:1, pages 11-17.
Crossref
Crossref
Prathima Setty, Laura Redekal & Michelle P. Warren. (2016) Vaginal estrogen use and effects on quality of life and urogenital morbidity in postmenopausal women after publication of the Women's Health Initiative in New York City. Menopause 23:1, pages 7-10.
Crossref
Crossref
Berihun M. Zeleke, Robin J. Bell, Baki Billah & Susan R. Davis. (2016) Vasomotor and sexual symptoms in older Australian women: a cross-sectional study. Fertility and Sterility 105:1, pages 149-155.e1.
Crossref
Crossref
Nicoletta Biglia, Valentina E. Bounous, Luca G. Sgro, Marta D'Alonzo, Silvia Pecchio & Rossella E. Nappi. (2015) Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?. Clinical Breast Cancer 15:6, pages 413-420.
Crossref
Crossref
Rossella E. Nappi & Barbara Gardella. 2015. Managing the Menopause. Managing the Menopause
52
57
.
Pragya Gartoulla, Roisin Worsley, Robin J. Bell & Susan R. Davis. (2015) Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause 22:7, pages 694-701.
Crossref
Crossref
Paula R. DeCola. 2015. Skin, Mucosa and Menopause. Skin, Mucosa and Menopause
495
509
.
. (2014) RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause. Journal of Obstetrics and Gynaecology Canada 36:9, pages S59-S73.
Crossref
Crossref
Dudley Robinson, Linda Cardozo, Ian Milsom, Montserrat Espuna Pons, Michael Kirby, Heinz Koelbl & Mark Vierhout. (2014) Oestrogens and overactive bladder. Neurourology and Urodynamics 33:7, pages 1086-1091.
Crossref
Crossref
Anne Whitney Ensor & Roberta A. Newton. (2014) The Role of Biofeedback and Soft Tissue Mobilization in the Treatment of Dyspareunia. Journal of Women's Health Physical Therapy 38:2, pages 74-80.
Crossref
Crossref
Rossella E Nappi, Ellis Martini, Silvia Martella, Francesca Capuano, David Bosoni, Sonia Giacomini, Matteo Beraghi & Arsenio Spinillo. (2014) Maintaining sexuality in menopause. Post Reproductive Health 20:1, pages 22-29.
Crossref
Crossref
Yunus Aydin, Hikmet Hassa, Tufan Oge, Omer Tarik Yalcin & Fezan Şahin Mutlu. (2014) Frequency and determinants of urogenital symptoms in postmenopausal Islamic women. Menopause 21:2, pages 182-187.
Crossref
Crossref
Rogerio A. Lobo. 2014. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology
308
339.e8
.
Silvia Pisaneschi, Giulia Palla, Stefania Spina, Guja Bernacchi, Elena Cecchi, Silvia Di Bello, Magdalena Montt Guevara, Adrian Campelo & Tommaso Simoncini. 2014. Frontiers in Gynecological Endocrinology. Frontiers in Gynecological Endocrinology
215
224
.
Daniel Zainfeld & Priya Padmanabhan. 2014. Geriatric Urology. Geriatric Urology
369
376
.
Christiana Campani Nygaard, Cornelia Betschart, Ahmed A. Hafez, Erica Lewis, Ilias Chasiotis & Stergios K. Doumouchtsis. (2013) Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. International Urogynecology Journal 24:12, pages 2071-2076.
Crossref
Crossref
Paolo Mannella, Giulia Palla, Massimo Bellini & Tommaso Simoncini. (2013) The female pelvic floor through midlife and aging. Maturitas 76:3, pages 230-234.
Crossref
Crossref
Andrea Salonia, Maria Chiara Clementi, Alessandra Graziottin, Rossella E. Nappi, Fabio Castiglione, Matteo Ferrari, Umberto Capitanio, Rocco Damiano & Francesco Montorsi. (2013) Secondary Provoked Vestibulodynia in Sexually Active Women with Uncomplicated Recurrent Urinary Tract Infections. The Journal of Sexual Medicine 10:9, pages 2265-2273.
Crossref
Crossref
. (2013) Management of symptomatic vulvovaginal atrophy. Menopause 20:9, pages 888-902.
Crossref
Crossref
Irwin Goldstein. (2012) The Effects of the Women's Health Initiative on Its 10th Year Anniversary. The Journal of Sexual Medicine 9:10, pages 2479-2482.
Crossref
Crossref